Walgreens Boots Alliance, Inc. (WBA) Financials

Stock symbol WBA is outdated, potentially delisted? Maybe it is available on other exchange?

WBA Assets vs Liabilities

Date	Assets	Liabilities
May 31, 2025	69.4 billion	62.1 billion
Feb. 28, 2025	70.2 billion	63.0 billion
Nov. 30, 2024	78.5 billion	67.3 billion
Aug. 31, 2024	81.0 billion	68.9 billion

WBA Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
May 31, 2025	336.0 million	41.0 million
Feb. 28, 2025	-418.0 million	21.0 million
Nov. 30, 2024	-424.0 million	38.0 million
Aug. 31, 2024	1.1 billion	39.0 million

WBA Net Income

Graph available only for paid members. Upgrade to see it.

Date	Net Income
May 31, 2025	-196.0 million
Feb. 28, 2025	-4.0 billion
Nov. 30, 2024	-605.0 million
Aug. 31, 2024	-3.1 billion

WBA Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
May 31, 2025	830.0 million	26.2 billion	21.7 billion
Feb. 28, 2025	1.1 billion	27.2 billion	20.6 billion
Nov. 30, 2024	1.2 billion	27.9 billion	20.3 billion
Aug. 31, 2024	3.1 billion	29.9 billion	24.2 billion

WBA Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
May 31, 2025	865.2 million
Feb. 28, 2025	864.1 million
Nov. 30, 2024	863.8 million
Aug. 31, 2024	863.7 million

WBA Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
May 31, 2025	248.0 million	-	6.5 billion	-
Feb. 28, 2025	219.0 million	-	8.9 billion	-
Nov. 30, 2024	284.0 million	-	7.0 billion	-
Aug. 31, 2024	246.0 million	414.0 million	6.9 billion	694.0 million

WBA Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
May 31, 2025	39.0 billion	32.5 billion
Feb. 28, 2025	38.6 billion	31.7 billion
Nov. 30, 2024	39.5 billion	32.7 billion
Aug. 31, 2024	37.5 billion	31.3 billion

WBA Revenue by Segment

Graph available only for paid members. Upgrade to see it.

WBA

Price: $11.98

52 week price:

8.08

13.25

Dividend Yield: 2.09%

5-year range yield:

2.09%

10.80%

Forward Dividend Yield: 8.35%

Payout Ratio: -14.84%

Payout Ratio Range:

-619.40%

1426.92%

Dividend Per Share: 1.00 USD

Earnings Per Share: -7.29 USD

P/E Ratio: -1.64

Exchange: NMS

Sector: Healthcare

Industry: Pharmaceutical Retailers

Country: United States

Volume: 5.5 million

Ebitda: 1.7 billion

Market Capitalization: 10.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 40

DGR3: -15.44%

DGR5: -8.22%

DGR10: -0.82%

DGR20: 10.20%

Links:

WBA on Yahoo Finance